| Ticker Details |
|
Edesa Biotech, Inc.
|
| IPO Date: |
June 25, 2010 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$12.17M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.15 | 3.80%
|
| Avg Daily Range (30 D): |
$0.05 | 3.15%
|
| Avg Daily Range (90 D): |
$0.06 | 3.09%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.32M |
| Avg Daily Volume (30 D): |
.03M |
| Avg Daily Volume (90 D): |
.17M |
| Trade Size |
| Avg Trade Size (Sh.): |
158 |
| Avg Trade Size (Sh.) (30 D): |
255 |
| Avg Trade Size (Sh.) (90 D): |
94 |
| Institutional Trades |
| Total Institutional Trades: |
11 |
| Avg Institutional Trade: |
$1.16M |
| Avg Institutional Trade (30 D): |
$M |
| Avg Institutional Trade (90 D): |
$M |
| Avg Institutional Trade Volume: |
.01M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-1.27
|
$-.32
|
$-1.27
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
|
|
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-7.19M
|
$-2.23M
|
$-7.19M
|
|
Operating Income / Loss
|
$-7.91M
|
$-2.47M
|
$-7.91M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$M
|
$M
|
$M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Oct 11, 2023
|
1:7
|
|
Jun 10, 2019
|
1:6
|
|
May 07, 2018
|
1:7
|
|
Sep 02, 2015
|
1:10
|
|
|
|